Reversion of age-related recognition memory impairment by iron chelation in rats

被引:41
作者
Martins de Lima, Maria Noemia [1 ,2 ]
Dias, Caroline Pieta [1 ,2 ]
Torres, Juliana Presti [1 ,3 ]
Dornelles, Arethuza [1 ,3 ]
Garcia, Vanessa Athaide [1 ]
Scalco, Felipe Siciliani [1 ]
Guimaraes, Marcelo Rewsaat [1 ]
Petry, Roberta Cristina [1 ]
Bromberg, Elke [1 ,2 ]
Constantino, Larissa [4 ]
Budni, Patricia [4 ]
Dal-Pizzol, Felipe [4 ]
Schroeder, Nadja [1 ,2 ,3 ]
机构
[1] Pontif Catholic Univ, Dept Physiol Sci, Fac Biosci, Neurobiol & Dev Biol Lab, BR-90619900 Porto Alegre, RS, Brazil
[2] Pontif Catholic Univ, Sao Lucas Hosp, Grad Program Biomed Gerontol, Inst Gerontol & Geriatr, BR-90619900 Porto Alegre, RS, Brazil
[3] Pontif Catholic Univ, Grad Program Cellular & Mol Biol, Fac Biosci, BR-90619900 Porto Alegre, RS, Brazil
[4] Univ So Santa Catarina, Dept Med, Phytopathol Lab, BR-88806000 Criciuma, SC, Brazil
关键词
aging; recognition memory; desferoxamine; neuroprotection; iron; oxidative stress; protein carbonyl; rat;
D O I
10.1016/j.neurobiolaging.2007.02.006
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
It is now generally accepted that iron accumulates in the brain during the ageing process. Increasing evidence demonstrate that iron accumulation in selective regions of the brain may generate free radicals, thereby possessing implications for the etiology of neurodegenerative disorders. In a previous study we have reported that aged rats present recognition memory deficits. The aim of the present study was to evaluate the effect of desferoxamine (DFO), an iron chelator agent, on age-induced memory impairment. Aged Wistar rats received intraperitoneal injections of saline or DFO (300 mg/kg) for 2 weeks. The animals were submitted to a novel object recognition task 24 h after the last injection. DFO-treated rats showed normal recognition memory while the saline group showed long-term recognition memory deficits. The results show that DFO is able to reverse age-induced recognition memory deficits. We also demonstrated that DFO reduced the oxidative damage to proteins in cortex and hippocampus. Thus, the present findings provide the first evidence that iron chelators might prevent age-related memory dysfunction. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1052 / 1059
页数:8
相关论文
共 73 条
[1]   Of metals, mice, and men: what animal models can teach us about body iron loading [J].
Anderson, GJ ;
Powell, LW .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1185-1186
[2]  
Bartzokis G, 2000, CELL MOL BIOL, V46, P821
[3]   Increased basal ganglia iron levels in Huntington disease [J].
Bartzokis, G ;
Cummings, J ;
Perlman, S ;
Hance, DB ;
Mintz, J .
ARCHIVES OF NEUROLOGY, 1999, 56 (05) :569-574
[4]   Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats [J].
Ben Shachar, D ;
Kahana, N ;
Kampel, V ;
Warshawsky, A ;
Youdim, MBH .
NEUROPHARMACOLOGY, 2004, 46 (02) :254-263
[5]   FERRITIN, TRANSFERRIN, AND IRON IN SELECTED REGIONS OF THE ADULT AND AGED RAT-BRAIN [J].
BENKOVIC, SA ;
CONNOR, JR .
JOURNAL OF COMPARATIVE NEUROLOGY, 1993, 338 (01) :97-113
[6]   THE IRON CHELATOR DESFERRIOXAMINE (DESFERAL) RETARDS 6-HYDROXYDOPAMINE-INDUCED DEGENERATION OF NIGROSTRIATAL DOPAMINE NEURONS [J].
BENSHACHAR, D ;
ESHEL, G ;
FINBERG, JPM ;
YOUDIM, MBH .
JOURNAL OF NEUROCHEMISTRY, 1991, 56 (04) :1441-1444
[7]  
Bertaina-Anglade V., 2006, Journal of Pharmacological and Toxicological Methods, V54, P99, DOI 10.1016/j.vascn.2006.04.001
[8]   Iron: A pathological mediator of Alzheimer disease? [J].
Bishop, GM ;
Robinson, SR ;
Liu, Q ;
Perry, G ;
Atwood, CS ;
Smith, MA .
DEVELOPMENTAL NEUROSCIENCE, 2002, 24 (2-3) :184-187
[9]   STUDIES ON LIPID-PEROXIDATION AND PROTEIN OXIDATION IN THE AGING BRAIN [J].
CINI, M ;
MORETTI, A .
NEUROBIOLOGY OF AGING, 1995, 16 (01) :53-57
[10]  
CONNOR JR, 1995, J NEUROCHEM, V65, P717